Keywords: تادالافیل; Endometrial thickness; Tadalafil; Clomiphene citrate; Ovulation induction;
مقالات ISI تادالافیل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تادالافیل; AR; adrenergic receptor; cGMP; cyclic guanosine monophosphate; KUB; kidney, ureter, and bladder; MET; medical expulsive therapy; PDE(-5); phosphodiesterase (type 5); USG; ultrasonography; Efficacy; Silodosin; Tadalafil; Tamsulosin; Ureteric calculi;
Keywords: تادالافیل; Burns; Tadalafil; Necrosis; Injury progression; Naproxen; N-Acetyl cysteine;
Keywords: تادالافیل; Tadalafil; Finasteride; Human plasma; Solid phase extraction; Validation; Liquid chromatography-tandem mass spectrometry;
Keywords: تادالافیل; Erectile dysfunction; Impotence; Phosphodiesterase (PDE) 5 inhibitors; Sildenafil; Tadalafil; Vardenafil;
Keywords: تادالافیل; Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms; Erectile Dysfunction; Fixed-Dose Combination; Tadalafil; Tamsulosin;
Keywords: تادالافیل; Erectile dysfunction drug; Non-arteritic anterior ischemic optic neuropathy; Phosphodiesterase 5 inhibitor; Pfizer; Sildenafil; Tadalafil; Vardenafil;
Keywords: تادالافیل; Hot-melt extrusion; Poor solubility; Tadalafil; Soluplus; Mannitol;
Keywords: تادالافیل; Tadalafil; Pulmonary hypertension; Phosphodiesterase type 5; Vascular remodeling; Pulmonary artery; Smooth muscle;
Keywords: تادالافیل; Phosphodiesterase Type 5 Inhibitors; Sildenafil; Tadalafil; Vardenafil; Avanafil;
Keywords: تادالافیل; Tadalafil; Oral films; Nanocrystals; HPMC; Vitamin E TPGS; Poloxamer; Surfactants;
Keywords: تادالافیل; Sildenafil; Tadalafil; Platelets; cGMP; LC-MS/MS;
Keywords: تادالافیل; Pulmonary arterial hypertension; Pulmonary langerhans cell histiocytosis; Phosphodiesterase-5 inhibitor; Tadalafil
Keywords: تادالافیل; erectile dysfunction; PDE5 inhibitor; sildenafil; tadalafil; vardenafil
Keywords: تادالافیل; Erectile Dysfunction; Benign Prostatic Hyperplasia; Phosphodiesterase Type 5 Inhibitors; Tadalafil; Testosterone; Luteinizing Hormone;
Keywords: تادالافیل; Ischemia/reperfusion; Liver; Pentoxifylline; Tadalafil
Keywords: تادالافیل; Phosphodiesterase type 5 inhibitors; Lower urinary tract symptoms; Benign prostatic enlargement; Benign prostatic hyperplasia; Erectile dysfunction; Sildenafil; Vardenafil; Tadalafil; Avanafil; Prostate;
Keywords: تادالافیل; Silicosis; TGFβ1; TNFα; Airway hyperactivity; Tadalafil; Phosphodiesterase-5;
Keywords: تادالافیل; Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitors; Tadalafil; Data Pooling; Treatment Efficacy;
Keywords: تادالافیل; Tadalafil; Soluplus®; High energy ball milling; Supercritical fluids; Glassy molecular alloys; Solid dispersions; Dissolution enhancement;
Keywords: تادالافیل; antimicrobial susceptibility; ciprofloxacin; MIC; PDEi; sildenafil; tadalafil; vardenafil
Keywords: تادالافیل; Tadalafil; Bladder; Prostate; Blood flow; Benign prostatic hyperplasia;
Keywords: تادالافیل; Erectile dysfunction; Incontinence; Radical prostatectomy; Tadalafil
Keywords: تادالافیل; Tadalafil; Brachytherapy; Prostate cancer; EPIC; Erectile dysfunction;
Keywords: تادالافیل; Tadalafil; crystal structure; solvate; X-ray diffractometry; solid-state NMR; molecular modeling; thermal analysis; desolvation;
Keywords: تادالافیل; Benign prostatic hyperplasia; International prostate symptom score; Lower urinary tract symptoms; Storage; Tadalafil; Voiding
Keywords: تادالافیل; prostate; lower urinary tract symptoms; tadalafil; treatment outcome; questionnairesBII, BPH Impact Index; BPH, benign prostatic hyperplasia; CMI, clinically meaningful improvement; I-PSS, International Prostate Symptom Score; LS, least squares; LUTS, low
Keywords: تادالافیل; Ischemia reperfusion; Kidney; Tadalafil
Keywords: تادالافیل; 5‐Alpha Reductase Inhibitors; Benign Prostatic Hyperplasia; Ejaculatory Function; Erectile Dysfunction; Finasteride; Lower Urinary Tract Symptoms; Orgasmic Function; Phosphodiesterase Type 5 Inhibitors; Tadalafil
Keywords: تادالافیل; Tadalafil; Apparent solubility; Supersaturation; Dissolution rate; Freeze-drying; Solid dispersion; Polymer; Amorphous drug;
Keywords: تادالافیل; CDDP; cisplatin; GSH; reduced glutathione; MDA; malondialdehyde; NO; nitric oxide; cTn-I; cardiac troponin; PDE5; phosphodiesterase-5 enzyme; i.p.; intraperitoneally; cAMP; cyclic adenosine monophosphate; cGMP; cyclic guanosine monophosphate; CAD; coronar
Keywords: تادالافیل; Dog; Phosphodiesterase type 5 (PDE5) inhibitor; Pulmonary arterial hypertension; Tadalafil; Hemodynamic
Keywords: تادالافیل; Bosentan; Ambrisentan; Sildenafil; Tadalafil; LC–MS/MS
Keywords: تادالافیل; prostate; prostatic hyperplasia; lower urinary tract symptoms; tadalafil; drug evaluation5ARI, 5α-reductase inhibitor; BOO, bladder outlet obstruction; BOOI, BOO index; BPH, benign prostatic hyperplasia; BPO, benign prostatic obstruction; LUTS, lower urin
Keywords: تادالافیل; Tadalafil; Hippocampus; Phosphodiesterase; Memory;
Keywords: تادالافیل; Amorphous drugs; Tadalafil; Apparent solubility; Dissolution rate; Precipitation from solution
Keywords: تادالافیل; Pyelonephritis; Phosphodiesterase 5; Tadalafil; Renal damage;
Keywords: تادالافیل; Tamsulosin; Tadalafil; Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms; Erectile Dysfunction; Medical Therapy
Keywords: تادالافیل; Doxorubicin; Cardiomyopathy; Tadalafil; Cardiomyocyte atrophy; Myocardial fibrosis;
Keywords: تادالافیل; Sildenafil; Tadalafil; Chlorination; Acute and chronic toxicity tests; Mutagenesis; Genotoxicity;
Keywords: تادالافیل; Orodispersible films; Drug printing; Individualised medicine; Rasagiline; Tadalafil; Flexographic printing;
Uso de tadalafilo en la rehabilitación de pacientes con antecedente de lesión de uretra posterior en el contexto de fractura pélvica
Keywords: تادالافیل; Disfunción eréctil; Lesión uretral; Tadalafilo; Erectile dysfunction; Urethral injury; Tadalafil;
Pt nanoparticles supported on nitrogen-doped porous graphene for sensitive detection of Tadalafil
Keywords: تادالافیل; Tadalafil; Porous graphene; Pt nanoparticles; Nitrogen-doping;
An immunohistochemical and ultrastructural analysis of the retina in tadalafil (Cialis) treated rats
Keywords: تادالافیل; Retina; Tadalafil; Cialis; PDE5; Bcl-2; Immunohistochemistry; Ultrastructure;
Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression
Keywords: تادالافیل; ALS; amyotrophic lateral sclerosis; ChAT; choline acetyltransferase; FTD; frontotemporal dementia; IGF-II; insulin-like growth factor II; IGF-IIR; IGF-II/cation-independent mannose-6-phosphate receptor; IGF-IR; IGF-I receptor; isl-1/2; islet 1 and 2; iPSC
Quantitation of tadalafil in human plasma using a sensitive and rapid LC-MS/MS method for a bioequivalence study
Keywords: تادالافیل; Tadalafil; Tadalafil-d3; LC-MS/MS; Sensitive; Bioequivalence study; Human plasma;
Antinociceptive effect of tadalafil in various pain models: Involvement of opioid receptors and nitric oxide cyclic GMP pathway
Keywords: تادالافیل; Analgesic; Nitric oxide; Nociception; Phosphodiesterase inhibitor; Tadalafil;
A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements
Keywords: تادالافیل; PDE-5i; sildenafil; tadalafil; vardenafil; dietary supplements; Mass Spectrometry; NMR;
Comparing the Efficacy of Tadalafil Versus Placebo on Pulmonary Artery Systolic Pressure and Right Ventricular Function in Patients with Beta-Thalassaemia Intermedia
Keywords: تادالافیل; Beta-thalassaemia intermedia; Pulmonary hypertension; Right ventricular systolic function; Tadalafil;
Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats
Keywords: تادالافیل; TDF; tadalafil; SD; solid dispersion; DW; distilled water; SLS; sodium lauryl sulfate; PVP/VA S-630 or PVP/VA 64, 60% VP and 40% VA, MW 50,000; poly(vinyl pyrrolidone-covinyl acetate); PVP, Kollidon K25, K30; polyvinylpyrrolidone; AUClast; the area under